Efficacy and Safety of Masitinib in the Treatment of Progressive Multiple Sclerosis

Clinical trial NCT01433497 · COMPLETED

Trial details

NCT number: NCT01433497
Sponsor: AB Science
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Multiple Sclerosis, Secondary Progressive Multiple Sclerosis, Primary Progressive Multiple Sclerosis, Relapse Free

Start date: 2011-08-01
Primary completion: 2019-09-01
Enrollment: 656

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.